$2.65 Billion is the total value of QVT Financial LP's 71 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 34.7% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
AXGT | New | AXOVANT SCIENCES LTD | $1,050,000,000 | – | 75,000,000 | +100.0% | 39.58% | – |
XBI | Buy | SPDR SERIES TRUSTput | $316,986,000 | +37.8% | 4,781,800 | +12.4% | 11.95% | -24.5% |
MICROCHIP TECHNOLOGY INCsdcv 2.125%12/1 | $82,376,000 | +23.1% | 31,764,000 | 0.0% | 3.10% | -32.6% | ||
Sell | VERISIGN INCsdcv 3.250% 8/1 | $79,419,000 | -21.9% | 34,600,000 | -13.5% | 2.99% | -57.2% | |
Buy | TAL ED GROUPnote 2.500% 5/1 | $78,913,000 | +37.3% | 29,000,000 | +20.8% | 2.98% | -24.8% | |
GS | Sell | GOLDMAN SACHS GROUP INC | $68,952,000 | -11.7% | 427,558 | -18.7% | 2.60% | -51.7% |
New | NOVELLUS SYS INCnote 2.625% 5/1 | $56,518,000 | – | 20,193,000 | +100.0% | 2.13% | – | |
ABUS | New | ARBUTUS BIOPHARMA CORP | $55,087,000 | – | 16,013,540 | +100.0% | 2.08% | – |
Buy | SHIP FINANCE INTERNATIONAL Lnote 3.250% 2/0 | $43,674,000 | +8.4% | 40,500,000 | +6.6% | 1.65% | -40.7% | |
MMYT | Sell | MAKEMYTRIP LIMITED MAURITIUS | $39,612,000 | +36.6% | 1,794,024 | -11.8% | 1.49% | -25.2% |
INTC | INTEL CORP | $35,108,000 | +15.1% | 930,004 | 0.0% | 1.32% | -37.0% | |
Sell | CLOVIS ONCOLOGY INCnote 2.500% 9/1 | $34,670,000 | +11.8% | 36,295,000 | -16.2% | 1.31% | -38.8% | |
Buy | WELLPOINT INCnote 2.750%10/1 | $32,718,000 | +7.9% | 18,500,000 | +12.1% | 1.23% | -40.9% | |
CTRIP COM INTL LTDnote 1.250%10/1 | $32,437,000 | +5.9% | 25,000,000 | 0.0% | 1.22% | -42.0% | ||
SRPT | Buy | SAREPTA THERAPEUTICS INC | $30,486,000 | +288.9% | 496,434 | +20.8% | 1.15% | +112.8% |
IBB | Buy | ISHARES TRnasdq biotec etf | $27,131,000 | +75.2% | 93,730 | +55.8% | 1.02% | -4.0% |
NRE | Sell | NORTHSTAR REALTY EUROPE CORP | $25,339,000 | +15.7% | 2,314,090 | -2.3% | 0.96% | -36.7% |
NYT | Sell | NEW YORK TIMES COcl a | $23,295,000 | -17.3% | 1,949,409 | -16.3% | 0.88% | -54.7% |
AGEN | Sell | AGENUS INC | $23,110,000 | +55.1% | 3,218,707 | -12.5% | 0.87% | -15.0% |
XLRN | Sell | ACCELERON PHARMA INC | $23,044,000 | -3.5% | 636,764 | -9.3% | 0.87% | -47.1% |
Sell | INTEL CORPsdcv 12/1 | $21,557,000 | -16.6% | 15,500,000 | -22.5% | 0.81% | -54.3% | |
COG | New | CABOT OIL & GAS CORP | $21,278,000 | – | 824,742 | +100.0% | 0.80% | – |
EQC | Sell | EQUITY COMWLTH | $20,550,000 | -11.8% | 680,000 | -15.0% | 0.78% | -51.7% |
AMBA | New | AMBARELLA INC | $20,307,000 | – | 275,877 | +100.0% | 0.77% | – |
KANG | Buy | IKANG HEALTHCARE GROUP INCsponsored adr | $20,225,000 | +23.6% | 1,118,340 | +25.4% | 0.76% | -32.3% |
ARWR | Buy | ARROWHEAD PHARMACEUTICALS IN | $18,788,000 | +72.5% | 2,556,256 | +24.8% | 0.71% | -5.6% |
ATEX | PDVWIRELESS INC | $18,466,000 | +4.3% | 902,599 | 0.0% | 0.70% | -42.9% | |
NAT | Sell | NORDIC AMERICAN TANKERS LIMIput | $17,768,000 | -29.4% | 1,757,500 | -3.0% | 0.67% | -61.3% |
THC | Sell | TENET HEALTHCARE CORP | $15,335,000 | -30.2% | 676,765 | -14.8% | 0.58% | -61.7% |
DHT HOLDINGS INCdebt 4.500%10/0 | $15,172,000 | -5.2% | 17,000,000 | 0.0% | 0.57% | -48.0% | ||
MRVL | Sell | MARVELL TECHNOLOGY GROUP LTDord | $15,118,000 | +12.4% | 1,139,262 | -19.3% | 0.57% | -38.4% |
ICPT | Buy | INTERCEPT PHARMACEUTICALS IN | $15,123,000 | +44.7% | 91,881 | +25.4% | 0.57% | -20.7% |
LBIO | Buy | LION BIOTECHNOLOGIES INC | $14,335,000 | +10.7% | 1,751,509 | +9.6% | 0.54% | -39.4% |
CTRIP COM INTL LTDnote 1.000% 7/0 | $14,166,000 | +3.2% | 13,000,000 | 0.0% | 0.53% | -43.5% | ||
PYPL | New | PAYPAL HLDGS INC | $14,101,000 | – | 344,190 | +100.0% | 0.53% | – |
XLNX | XILINX INC | $12,871,000 | +17.8% | 236,855 | 0.0% | 0.48% | -35.5% | |
BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $12,391,000 | +63.8% | 133,933 | +37.7% | 0.47% | -10.4% |
TSM | TAIWAN SEMICONDUCTOR MFG LTDput | $12,236,000 | +16.6% | 400,000 | 0.0% | 0.46% | -36.1% | |
Sell | WEBMD HEALTH CORPnote 2.500% 1/3 | $11,490,000 | -17.3% | 11,000,000 | -12.0% | 0.43% | -54.7% | |
WFC | Sell | WELLS FARGO & CO NEW | $11,291,000 | -27.7% | 255,000 | -22.7% | 0.43% | -60.4% |
BRFS | BRF SAsponsored adr | $10,357,000 | +22.5% | 607,112 | 0.0% | 0.39% | -33.0% | |
YY | New | YY INC | $10,160,000 | – | 190,700 | +100.0% | 0.38% | – |
AR | New | ANTERO RES CORP | $10,063,000 | – | 373,413 | +100.0% | 0.38% | – |
AVXS | Sell | AVEXIS INC | $9,262,000 | +3.4% | 224,756 | -7.4% | 0.35% | -43.4% |
TNK | TEEKAY TANKERS LTDcl a | $9,247,000 | -15.1% | 3,654,776 | 0.0% | 0.35% | -53.5% | |
XNCR | Sell | XENCOR INC | $8,740,000 | +18.9% | 356,873 | -7.8% | 0.33% | -35.0% |
FIT | FITBIT INCcl a | $8,600,000 | +21.4% | 579,502 | 0.0% | 0.32% | -33.5% | |
EPZM | Sell | EPIZYME INC | $8,368,000 | -15.9% | 850,446 | -12.5% | 0.32% | -54.0% |
SCTY | SOLARCITY CORP | $7,957,000 | -18.3% | 406,816 | 0.0% | 0.30% | -55.2% | |
SCTY | SOLARCITY CORPput | $7,941,000 | -18.3% | 406,000 | 0.0% | 0.30% | -55.3% | |
BLCM | Sell | BELLICUM PHARMACEUTICALS INC | $7,738,000 | +17.5% | 388,839 | -23.4% | 0.29% | -35.5% |
JPM | Sell | JPMORGAN CHASE & CO | $7,325,000 | -34.5% | 110,000 | -38.9% | 0.28% | -64.2% |
ZXAIY | CHINA ZENIX AUTO INTL LTDads | $5,813,000 | +50.5% | 6,074,805 | 0.0% | 0.22% | -17.7% | |
New | INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $5,638,000 | – | 5,000,000 | +100.0% | 0.21% | – | |
BGNE | BEIGENE LTDsponsored adr | $5,238,000 | +3.4% | 170,000 | 0.0% | 0.20% | -43.6% | |
RGNX | Sell | REGENXBIO INC | $5,197,000 | +53.1% | 370,943 | -12.6% | 0.20% | -16.2% |
ADAP | Sell | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $5,092,000 | -20.3% | 722,233 | -7.8% | 0.19% | -56.4% |
ASMB | ASSEMBLY BIOSCIENCES INC | $5,059,000 | +35.3% | 807,601 | 0.0% | 0.19% | -25.7% | |
YY INCnote 2.250% 4/0 | $4,950,000 | +0.4% | 5,000,000 | 0.0% | 0.19% | -44.8% | ||
IMAX | New | IMAX CORP | $4,908,000 | – | 169,400 | +100.0% | 0.18% | – |
NAT | Sell | NORDIC AMERICAN TANKERS LIMI | $4,864,000 | -69.0% | 481,120 | -57.5% | 0.18% | -83.1% |
BLUE | BLUEBIRD BIO INC | $3,999,000 | +56.6% | 59,002 | 0.0% | 0.15% | -14.2% | |
FRO | FRONTLINE LTD | $2,930,000 | -8.5% | 408,341 | 0.0% | 0.11% | -50.0% | |
OCRX | OCERA THERAPEUTICS INC | $2,335,000 | +56.9% | 932,086 | 0.0% | 0.09% | -13.7% | |
TCON | Sell | TRACON PHARMACEUTICALS INC | $2,014,000 | +42.7% | 334,206 | -8.0% | 0.08% | -21.6% |
ATHM | New | AUTOHOME INCsp adr rp cl a | $1,974,000 | – | 81,400 | +100.0% | 0.07% | – |
AKTX | AKARI THERAPEUTICS PLCsponsored adr | $1,833,000 | -36.9% | 263,921 | 0.0% | 0.07% | -65.5% | |
PTN | PALATIN TECHNOLOGIES INC | $1,779,000 | +42.5% | 4,039,374 | 0.0% | 0.07% | -22.1% | |
SRLP | SPRAGUE RES LP | $844,000 | -12.4% | 39,979 | 0.0% | 0.03% | -51.5% | |
MDGN | Sell | MEDGENICS INC | $688,000 | -84.9% | 123,500 | -85.5% | 0.03% | -91.7% |
FCSC | Sell | FIBROCELL SCIENCE INC | $335,000 | -84.8% | 465,672 | -75.7% | 0.01% | -91.4% |
DNAI | Exit | PRONAI THERAPEUTICS INC | $0 | – | -70,000 | -100.0% | -0.01% | – |
FPRX | Exit | FIVE PRIME THERAPEUTICS INC | $0 | – | -48,582 | -100.0% | -0.14% | – |
ADRO | Exit | ADURO BIOTECH INC | $0 | – | -191,954 | -100.0% | -0.15% | – |
MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -509,750 | -100.0% | -0.19% | – |
Exit | ARRAY BIOPHARMA INCnote 3.000% 6/0 | $0 | – | -4,600,000 | -100.0% | -0.27% | – | |
HALO | Exit | HALOZYME THERAPEUTICS INC | $0 | – | -500,449 | -100.0% | -0.30% | – |
MFRM | Exit | MATTRESS FIRM HLDG CORP | $0 | – | -130,738 | -100.0% | -0.30% | – |
GLNG | Exit | GOLAR LNG LTD BERMUDA | $0 | – | -300,283 | -100.0% | -0.32% | – |
RLGY | Exit | REALOGY HLDGS CORP | $0 | – | -365,645 | -100.0% | -0.73% | – |
CYTR | Exit | CYTRX CORP | $0 | – | -5,423,037 | -100.0% | -0.83% | – |
ZG | Exit | ZILLOW GROUP INCcl a | $0 | – | -600,000 | -100.0% | -1.51% | – |
MU | Exit | MICRON TECHNOLOGY INCcall | $0 | – | -1,700,000 | -100.0% | -1.61% | – |
Z | Exit | ZILLOW GROUP INCcl c cap stk | $0 | – | -665,000 | -100.0% | -1.66% | – |
Exit | WESCO INTL INCdbcv 6.000% 9/1 | $0 | – | -13,550,000 | -100.0% | -1.69% | – | |
QIHU | Exit | QIHOO 360 TECHNOLOGY CO LTDads | $0 | – | -734,731 | -100.0% | -3.69% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MAKEMYTRIP LIMITED MAURITIUS | 38 | Q3 2023 | 6.2% |
NEW YORK TIMES CO | 34 | Q3 2023 | 2.6% |
ACCELERON PHARMA INC | 32 | Q3 2021 | 2.8% |
JPMORGAN CHASE & CO | 32 | Q3 2021 | 2.2% |
SAREPTA THERAPEUTICS INC | 32 | Q3 2023 | 1.1% |
BIOMARIN PHARMACEUTICAL INC | 32 | Q3 2023 | 0.5% |
GOLDMAN SACHS GROUP INC | 30 | Q3 2023 | 5.4% |
ACADIA PHARMACEUTICALS INC | 28 | Q3 2023 | 0.2% |
WELLS FARGO CO NEW | 27 | Q4 2020 | 1.5% |
NEXSTAR MEDIA GROUP INC | 26 | Q3 2023 | 3.4% |
View QVT Financial LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
MP Materials Corp. / DE | May 18, 2023 | 8,853,712 | 5.0% |
Grindrod Shipping Holdings Ltd.Sold out | February 14, 2022 | 0 | 0.0% |
AEHR TEST SYSTEMSSold out | February 14, 2020 | 0 | 0.0% |
Arbutus Biopharma CorpSold out | July 12, 2019 | 0 | 0.0% |
Axovant Gene Therapies Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
Myovant Sciences Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
Urovant Sciences Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
Axovant Sciences Ltd. | March 19, 2019 | 105,952,381 | 58.2% |
Hunter Maritime Acquisition Corp.Sold out | February 14, 2019 | 0 | 0.0% |
AGENUS INC | February 14, 2018 | 3,201,263 | 3.2% |
View QVT Financial LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
4 | 2024-03-07 |
SC 13G/A | 2024-03-07 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2023-11-14 |
4 | 2023-10-02 |
144 | 2023-09-28 |
13F-HR | 2023-08-14 |
SC 13D/A | 2023-05-18 |
13F-HR | 2023-05-15 |
View QVT Financial LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.